Last reviewed · How we verify
Novel CAR-T
Novel CAR-T is a Biologic drug developed by Timmune Biotech Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Novel CAR-T |
|---|---|
| Sponsor | Timmune Biotech Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma (NA)
- A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases (EARLY_PHASE1)
- Clinical Study of AFN50 Injection in the Autoimmune Diseases (EARLY_PHASE1)
- Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells (PHASE1)
- T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma (PHASE1)
- A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases (PHASE1)
- Study of AZD0754 in Participants With Metastatic Prostate Cancer (PHASE1, PHASE2)
- Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Novel CAR-T CI brief — competitive landscape report
- Novel CAR-T updates RSS · CI watch RSS
- Timmune Biotech Inc. portfolio CI
Frequently asked questions about Novel CAR-T
What is Novel CAR-T?
Novel CAR-T is a Biologic drug developed by Timmune Biotech Inc..
Who makes Novel CAR-T?
Novel CAR-T is developed by Timmune Biotech Inc. (see full Timmune Biotech Inc. pipeline at /company/timmune-biotech-inc).
What development phase is Novel CAR-T in?
Novel CAR-T is in Phase 1.
Related
- Manufacturer: Timmune Biotech Inc. — full pipeline
- Compare: Novel CAR-T vs similar drugs
- Pricing: Novel CAR-T cost, discount & access